Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

Write your comment first

News feed

IST Group of Alexander Nesis withdrew from Polymetal capital

1/29/24 POLY

X5 Retail Group will build a large logistics center in the Tambov region

1/29/24 X5

Rosneft set a record for gas production

1/29/24 ROSN

Inter RAO completed modernization of power units with a total capacity of 1390 MW

1/29/24 IRAO

Angola has asked Alrosa to leave the Katoka diamond mine

1/29/24 ALRS

Repair of Lukoil's Nizhny Novgorod refinery will take at least 1-1.5 months

1/29/24 LKOH

Inter RAO reduced electricity exports by 21% in 2023

1/29/24 IRAO

Alrosa updated the capex assessment of the Mir mine

1/26/24 ALRS

Rosbank to change its head and update its strategy

1/26/24 ROSB

Marketplace Magnit Market will start operating in the first half of 2024

1/26/24 MGNT